Published in Clin Endocrinol (Oxf) on March 19, 2009
Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int (2011) 2.49
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone (2009) 1.47
Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007. J Bone Miner Res (2011) 1.23
Atypical fractures do not have a thicker cortex. Osteoporos Int (2012) 1.17
The effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res (2011) 1.10
Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India. Indian J Med Res (2011) 0.95
Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab (2013) 0.94
Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality. Arthritis Res Ther (2012) 0.94
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporos Int (2012) 0.90
Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases. Acta Orthop (2010) 0.88
Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report. Skeletal Radiol (2012) 0.87
Do bisphosphonates cause femoral insufficiency fractures? J Orthop Traumatol (2012) 0.87
Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J (2012) 0.87
Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res (2014) 0.84
Risk communication methods in hip fracture prevention: a randomised trial in primary care. Br J Gen Pract (2011) 0.83
Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis (2011) 0.83
Relating micromechanical properties and mineral densities in severely suppressed bone turnover patients, osteoporotic patients, and normal subjects. Bone (2012) 0.83
Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep (2017) 0.82
Long-Term Alendronate Use Not without Consequences? Int J Rheumatol (2010) 0.82
Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int (2014) 0.82
Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study. BMJ Open (2013) 0.79
The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int (2011) 0.79
Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases. Eur J Orthop Surg Traumatol (2014) 0.78
Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report. J Med Case Rep (2012) 0.78
Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss. Osteoporos Int (2013) 0.78
The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. Oncologist (2011) 0.78
Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient. Caspian J Intern Med (2014) 0.78
The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int (2016) 0.78
Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer. Nagoya J Med Sci (2011) 0.77
Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur? Hip Pelvis (2015) 0.75
Acute nontraumatic clavicle fracture associated with long-term bisphosphonate therapy. Case Rep Orthop (2014) 0.75
Bone Density Screening and Re-screening in Postmenopausal Women and Older Men. Curr Osteoporos Rep (2015) 0.75
Delayed healing of lower limb fractures with bisphosphonate therapy. Ann R Coll Surg Engl (2015) 0.75
Update in women's health for the general internist. J Gen Intern Med (2011) 0.75
Bisphosphonates and atypical fractures of femur. J Osteoporos (2011) 0.75
Long term bisphosphonate therapy & atypical femoral fractures: a word of caution. Indian J Med Res (2014) 0.75
Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab (2004) 8.36
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med (2007) 4.59
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest (1983) 4.53
The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int (1985) 2.44
Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther (1999) 2.14
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76
Bone loss and bone turnover in diabetes. Diabetes (1995) 1.74
Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin. Mol Cell Biol (2011) 1.70
Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr (1970) 1.57
Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res (2007) 1.48
Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44
Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens (2012) 1.43
ZnT-1 protects HL-1 cells from simulated ischemia-reperfusion through activation of Ras-ERK signaling. J Mol Med (Berl) (2011) 1.40
Anomalous origins of right coronary and left anterior descending coronary arteries: angiographic profiles. J Assoc Physicians India (2000) 1.39
A case of hemiparesis with systolic murmur at left sternal border. J Assoc Physicians India (1989) 1.39
Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery (2000) 1.33
MicroRNAs in inflammation and immune responses. Leukemia (2011) 1.33
Vitamin D and diabetes mellitus. Endocrine (2008) 1.29
Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med (2000) 1.29
Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res (1995) 1.28
Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res (1996) 1.14
Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med (1987) 1.14
Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol (2007) 1.14
Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol (2006) 1.13
Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res (1991) 1.13
Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med (1978) 1.13
Is there a difference between right and left femoral bone density? J Clin Densitom (2000) 1.11
Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res (1997) 1.11
Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone (2002) 1.10
Evidence for binding of rose bengal and anilinonaphthalenesulfonates at the active site regions of liver alcohol dehydrogenase. Biochemistry (1967) 1.09
Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis (2006) 1.09
Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab (1987) 1.04
Oro-mandibular manifestations of primary hyperparathyroidism. Indian J Dent Res (2012) 1.01
New cladiellane diterpenes from the soft coral Cladiella australis of the Andaman and Nicobar Islands. J Nat Prod (1994) 1.01
Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest (1985) 1.01
Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res (1997) 0.99
RGS13 controls g protein-coupled receptor-evoked responses of human mast cells. J Immunol (2008) 0.98
Gastrointestinal hemorrhage in Turner syndrome. Long-term follow-up with postmortem examination. Arch Intern Med (1977) 0.98
Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone (2002) 0.96
Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol (1998) 0.96
Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism. J Clin Endocrinol Metab (1996) 0.95
Orthotopic skin graft survival in rats that have harbored skin implants in the anterior chamber of the eye. Transplantation (1977) 0.91
A rare case of angioleiomyoma of the knee: a case report. Cases J (2009) 0.91
Immunosuppressive action of heat in chickens. Proc Soc Exp Biol Med (1970) 0.90
The mineralization index--a new approach to the histomorphometric appraisal of osteomalacia. Bone (2004) 0.90
Bone mineral density in diabetes. Diabetes Care (1997) 0.89
Acute severe hypercalcemia in a la Münchausen. Am J Med (1981) 0.88
Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase. J Cell Physiol (2009) 0.88
Angioleiomyoma of the knee: case series and an unusual cause of knee pain. J Knee Surg (2011) 0.87
Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. J Clin Endocrinol Metab (1985) 0.87
Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis. J Bone Miner Res (1991) 0.86
Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids (2001) 0.86
Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice *. J Bone Miner Res (2007) 0.86
Bone mineral density (BMD) in obesity effect of weight loss. J Med (1999) 0.85
Tetralogy of Fallot with flap valve ventricular septal defect producing suprasystemic right ventricular pressure: echocardiographic observations. Indian Heart J (1998) 0.85
Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy. J Clin Endocrinol Metab (2002) 0.85
Atypical tibial tuberosity fracture in an adolescent. Orthopedics (2011) 0.84
ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling. Am J Physiol Cell Physiol (2012) 0.84
Immunoglobulin-positive cells from the gland of harder and bone marrow of the chicken. Cell Immunol (1977) 0.84
Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone. Osteoporos Int (1998) 0.84
Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med J (2011) 0.83
Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol (2010) 0.83
Unruptured sinus of Valsalva aneurysm dissecting into ventricular septum: diagnosis by echocardiography. Indian Heart J (1998) 0.83
Gadolinium-enhanced three-dimensional magnetic resonance angiographic assessment of the pulmonary artery anatomy in cyanotic congenital heart disease with pulmonary stenosis or atresia: comparison with cineangiography. Pediatr Cardiol (2011) 0.83
The endocrine system in diabetes mellitus. Endocrine (2002) 0.82
Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis. Kidney Int (2008) 0.82
Effect of gender and geographic location on the expression of primary hyperparathyroidism. J Endocrinol Invest (2012) 0.82
Surgical management of persistence or recurrence after subtotal parathyroidectomy for primary hyperparathyroidism. Am J Surg (1979) 0.82
Atypical insufficiency fractures confused with Looser zones of osteomalacia. Bone (1987) 0.81
Cloning of rhesus monkey LILRs. Tissue Antigens (2006) 0.81
Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis. Arch Intern Med (2001) 0.81
Vitamin D is not an essential nutrient for Rora (Labeo rohita) as a representative of freshwater fish. J Nutr Sci Vitaminol (Tokyo) (1998) 0.80
Markedly low hemoglobin A1c in a patient with an unusual presentation of beta-thalassemia minor. Endocr Pract (2010) 0.80
Identifying lympholytic and androgenic effects of androgenic steroids. Gen Comp Endocrinol (1977) 0.80
Pressure-selective modulation of NMDA receptor subtypes may reflect 3D structural differences. Front Cell Neurosci (2012) 0.80
Hypercalcemia, primary hyperparathyroidism, and cardiac calcifications. Am J Med (1989) 0.80
Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite. J Urol (2009) 0.80
Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis. Urol Res (2008) 0.79
Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol (1995) 0.79
Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol (2001) 0.79
Photocontact dermatitis caused by Parthenium hysterophorus. Dermatologica (1978) 0.79
1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. Arch Biochem Biophys (2000) 0.78
Calcitropic hormonal status in north Indian patients with end-stage renal disease. Natl Med J India (2000) 0.78
[Clinical observation of 21 cases of Agkistrodon acutus (Guenther) bite complicated by disseminated intravascular coagulation (author's transl)]. Zhonghua Nei Ke Za Zhi (1981) 0.78
Differential effect of high pressure on NMDA receptor currents in Xenopus laevis oocytes. Diving Hyperb Med (2008) 0.77
The regulation of IgM production in the chick: roles of the bursa of fabricius, environmental antigens, and plasma IgG. J Immunol (1978) 0.77
Functional studies on long-term cryopreserved peripheral blood mononuclear cells from patients with lung cancer and from healthy subjects. J Lab Clin Med (1992) 0.77
LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography. J Pharm Biomed Anal (2000) 0.77
Vitamin D2 is not biologically active for Rora (Labeo rohita) as vitamin D3. J Nutr Sci Vitaminol (Tokyo) (1999) 0.76
Routine screening for HIV and hepatitis B in patients undergoing cardiac catheterisation: the need to make it mandatory. Indian Heart J (2000) 0.76
Endovascular stenting for native coarctation in older children and adolescents using adult self-expanding (Nitinol) iliac stents. Indian Heart J (2010) 0.75
A family with arrhythmogenic right ventricular dysplasia. Indian Heart J (1999) 0.75
Variability in urinary oxalate measurements between six international laboratories. Nephrol Dial Transplant (2011) 0.75
Primary hyperparathyroidism. A cause of hypercalciuria and renal stones in patients with medullary sponge kidney. JAMA (1977) 0.75
In vitro cytotoxicity of 5-aminosubstituted 20(S)-camptothecins. Part 1. Bioorg Med Chem (1999) 0.75
Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone (2006) 0.75
Safety of thrombolytic therapy following acute myocardial infarction in patients above 65 years. Indian Heart J (1998) 0.75
Spontaneous dissection of coronary artery causing anterior myocardial infarction in a young man. Indian Heart J (1997) 0.75
Vertebral hemangioma with spinal cord compression: the role of pre-operative embolisation. Indian Pediatr (1992) 0.75